The nature, biological characteristics, and contribution to organ physiology of skeletal stem cells are not completely determined. Chan et al. and Worthley et al. demonstrate that a stem cell for skeletal tissues, and a system of more restricted, downstream progenitors, can be identified in mice and demonstrate its role in skeletal tissue maintenance and regeneration.
organisms ranging from yeast to mice, indicating that generation of this gas may play a conserved protective role in many organisms, at least when generated at a specific concentration. In fact, H 2 S has been traditionally regarded as a toxic gas, but recent findings indicate that it functions as a signaling molecule with potential therapeutic applications in a variety of conditions, including its remarkable ability to induce suspended animation in mice. Hine and colleagues have identified specific dietary interventions that result in the generation of protective levels of H 2 S but also provided data that advance our understanding of the anti-aging mechanisms induced by CR/PR. The identification of drugs that induce the generation of protective levels of H 2 S while eliminating the risk of toxic side effects could have important clinical applications for the treatment of a variety of acute conditions, such as ischemia/ reperfusion and other types of damage associated with surgery. The chronic use of drugs promoting H 2 S for healthspan extension could instead be much more problematic, as it is difficult to predict what the side effects caused by long-term use could be. If the effects described in model organisms are conserved in humans, protein restriction without malnutrition or the consumption of plant-based proteins with low sulfur amino acid content may represent a safer strategy to induce H 2 S generation and take advantage of its protective effects.
The groundbreaking concept that bone, cartilage, marrow adipocytes, and hematopoiesis-supporting stroma could originate from a common progenitor and putative stem cell was surprising at the time when it was formulated (Owen and Friedenstein, 1988) . The putative stem cell, nonhematopoietic in nature, would be found in the postnatal bone marrow stroma, generate tissues previously thought of as foreign to each other, and support the turnover of tissues and organs that self-renew at a much slower rate compared to other tissues associated with stem cells (blood, epithelia) . This concept also connected bone and bone marrow as parts of a single-organ system, implying their functional interplay. For many years, the evidence underpinning the concept has been incomplete. While multipotency of stromal progenitors has been demonstrated by in vivo transplantation experiments, self-renewal, the defining property of a stem cell, has not been easily demonstrated until recently in humans (Sacchetti et al., 2007) and mice (Mé ndez-Ferrer et al., 2010) . Meanwhile, a confusing and plethoric terminology has been introduced into the literature, which diverted and confounded the search for a skeletal stem cell and its physiological significance (Bianco et al., 2013) .
Two studies in this issue of Cell (Chan et al., 2015; Worthley et al., 2015) , using a combination of rigorous single-cell analyses and lineage tracing technologies, mark significant steps toward rectifying the course of skeletal stem cell discovery by making several important points, within and beyond skeletal physiology.
First, a stem cell for skeletal tissues, and a system of more restricted, downstream progenitors can in fact be identified and linked to defined phenotype(s) in the mouse. The system is framed conceptually, and approached experimentally, similar to the hematopoietic system. Second, based on its assayable functions and potential, the stem cell at the top of the hierarchy is defined as a skeletal stem cell (SSC). As noted earlier (Sacchetti et al., 2007) (Bianco et al., 2013) , this term clarifies, well beyond semantics, that the range of tissues that the selfrenewing stromal progenitor (originally referred to as an ''osteogenic'' or ''stromal'' stem cell) (Owen and Friedenstein, 1988) can actually generate in vivo, overlaps with the range of tissues that make up the skeleton.
Third, these cells are spatially restricted, local residents of the bone/ bone marrow organ. The systemic circulation is not a sizable contributor to their recruitment to locally deployed functions.
Fourth, a native skeletogenic potential is inherent to the system of progenitor/ stem cells found in the skeleton, and internally regulated by bone morphogenetic protein (BMP) signaling. This is reflected in the expression of regulators and antagonists of BMP signaling within the system, highlighting potential feedback mechanisms modulating expansion or quiescence of specific cell compartments.
Fifth, in cells isolated from other tissues, an assayable skeletogenic potential is not inherent: it can only be induced de novo by BMP reprogramming. These two studies (Chan et al., 2015 , Worthley et al., 2015 corroborate the classical concept of ''determined'' and ''inducible'' skeletal progenitors (Owen and Friedenstein, 1988) : the former residing in the skeleton, the latter found in nonskeletal tissues; the former capable of generating skeletal tissues, in vivo and spontaneously, the latter requiring reprogramming signals in order to acquire a skeletogenic capacity; the former operating in physiological bone formation, the latter in unwanted, ectopic bone formation in diseases such as fibrodysplasia ossificans progressiva.
A major question revolving around the concept of a SSC is how and to what extent it would contribute to postnatal physiology and adaptive changes in bone and bone marrow. Chan et al. show that SSCs (recruited locally, without significant contribution from the systemic circulation) can contribute to fracture healing. Worthley et al. show that ablation of SSCs can affect bone mass, which represents the endpoint of bone growth and a measure of skeletal health and disease. However, more studies are needed to determine in a quantitative manner the direct contribution of stem and progenitor cells to postnatal bone formation, maintenance of the skeleton, and also to fracture healing. We also need a better understanding of the mechanisms underpinning, at a tissue level, the recruitment and contribution of SSCs to the key microscopic events of lifelong bone renewal, which is important for translation of biological insight into medicine. Species specificities in patterns of bone and bone marrow remodeling, including the rate of adipogenesis in adulthood and aging, encourage efforts toward the further dissection of the system of skeletal progenitors in humans.
Both classical (Owen and Friedenstein, 1988 ) and recent observations (Omatsu et al., 2010; Zhou et al., 2014) support the concept of a common (stromal) progenitor for bone, cartilage, and marrow adipocytes comprised in bone as an organ. However, the lineage tracing studies of Chan et al. and Worthley et al. showing that stromal cells, osteoblasts, and chondrocytes, but not adipocytes, are clonally derived from SCCs, challenges this concept at a glance. The osteochondral-stromal clonogenic progenitors highlighted by the two studies may not coincide, in space and time, with those assayed by other studies and identified as perisinusoidal reticular cells (Sacchetti et al., 2007) . Models accommodating spatially and temporally discrete cohorts of skeletal progenitors (Mizoguchi et al., 2014) need to be further explored. Indeed, in developing and growing bones, simultaneous, de novo chondrogenesis and osteogenesis in the absence of adipogenesis occurs at specific sites distinct from bone marrow and at different developmental times. Likewise, bone and stromal cells, but hardly any adipocytes, are formed in the primary spongiosa of a growing long bone. Adipogenesis in bone marrow is a postnatal event and does not begin until specific times and at specific sites in different bones. Bone cells and adipocytes, but not chondrocytes, are generated in the marrow environment of an adult, aging or diseased bone, in a balanced fashion that implies a functional relationship (Abdallah and Kassem, 2012) . Elucidating the relationship between bone and bone marrow fat will help tackling major clinically relevant issues such as osteoporosis and aging. This will also help to clarify the relationships, potential overlap, and at times apparent discrepancies, between several marker-defined populations of putative skeletal stem cells that have been proposed in multiple recent studies.
To optimize our ability to obtain specific skeletal tissues for medical application, the study by Chan et al. offers a glimpse of another facet of the biology of SSC lineages and progenitors. Chan et al. show that a homogeneous cell population inherently committed to chondrogenesis can alter its output to generate bone if cotransplanted with multipotent progenitors. Conversely, osteogenic cells can be shifted to a chondrogenic fate by blockade of vascular endothelial growth factor receptor, consistent with the avascular and hypoxic milieu of cartilage. This has two important implications: (1) commitment is flexible in the system; (2) the choir is as important as the soloist and can modulate the solo tune. Reversibility and population behavior thus emerge as two features that may be characteristic, albeit not unique, of the stromal system, resonating with conceptually comparable evidence in the human system 
